Minneapolis, Minnesota
Colorectal cancer clinical trials in Minneapolis, MN
24 colorectal cancer studies are recruiting participants at sites in Minneapolis as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Minneapolis at a glance
- 24 studies are recruiting at a site in Minneapolis.
- By phase: Phase 1 (2), Phase 1/2 (6), Phase 2 (2), Phase 2/3 (1), Phase 3 (4), No phase (4), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (15), industry (8), government (1).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Minneapolis
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study site
- University of Minnesota/Masonic Cancer Center
- Registry record
- NCT05863195 · updated
SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Full-Life Technologies UK Limited
- Study site
- Full-Life Technologies Investigational Site
- Registry record
- NCT07873450 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Minneapolis VA Medical Center
- Registry record
- NCT06995898 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT07018869 · updated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study site
- Abbott-Northwestern Hospital
- Registry record
- NCT03998202 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center · Minneapolis VA Medical Center
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT06418204 · updated
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT07283939 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- University of Minnesota/Masonic Cancer Center
- Registry record
- NCT05673148 · updated
Family Communications After Genetic Testing
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT07143487 · updated
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Study site
- M Health Fairview University of Minnesota Medical Center
- Registry record
- NCT06330064 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- Masonic Cancer Center University of Minnesota
- Registry record
- NCT05786924 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149
- Registry record
- NCT07023289 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- M Health Fairview University of Minnesota Medical Center
- Registry record
- NCT05919264 · updated
PRE-ISPY Phase I/II Oncology Platform Program
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- QuantumLeap Healthcare Collaborative
- Study site
- University of Minnesota Masonic Cancer Center
- Registry record
- NCT05868226 · updated
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Fate Therapeutics
- Study site
- University of Minnesota Masonic Cancer Center
- Registry record
- NCT07216105 · updated
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Phase 1/2
- From 12 months, up to 30 years
- All sexes
- Sponsor
- Children's Oncology Group
- Study site
- University of Minnesota/Masonic Cancer Center
- Registry record
- NCT04851119 · updated
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200
- Registry record
- NCT05005403 · updated
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University of Michigan Rogel Cancer Center
- Study site
- University of Minnesota
- Registry record
- NCT00843375 · updated
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT05855200 · updated
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University of Rochester
- Study sites
- Abbott-Northwestern Hospital · Hennepin County Medical Center
- Registry record
- NCT06073431 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Minneapolis, MN on ClinicalTrials.gov.
Ask about studies near Minneapolis
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Minnesota
All Minnesota locations
61 studies recruiting across 47 cities.
Rochester
30 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections